Introducing Cercle: Advancing women’s health through AI and secure data

May 3, 2023
By Juan Carlos Riveiro
The world's medical data accounts for at least 30% of all data. That's a ton of lab results, diagnoses, treatment plans and outcomes we could learn from to improve our collective health journey. The big problem standing in the way? Up to 80% of the world’s medical data is unstructured, meaning that information from hospitals and clinics around the world hasn’t been organized cohesively enough. We could learn so much from our medical histories, treatments and paths if there were a clear way to organize and analyze all that medical data. 

Thanks to advances in machine learning and AI, we now have the opportunity to safely analyze biomedical and genetics data to drive better health outcomes for all women. That’s the founding mission behind our company Cercle, where we’ve built the Cercle™ Biomedical Graph, a first-of-its-kind, rapidly growing biomedical graph fueled by billions of anonymized data points drawn from hospitals and clinics from all over the globe. 

Our goal is to help unlock a world where everyone feels informed, empowered, and in control of their own health.

You might be wondering: What is a biomedical graph and how does it work? Analyzing anonymized biomedical and genetics data with AI, we’ve built an accurate “map” that connects everything. This graph delivers unprecedented and secure healthcare insights for clinics, research, labs, providers and patients. Using what the FDA calls Real World Data (RWD) and Real World Evidence (RWE), the Cercle™ Biomedical Graph helps clinics understand new patients based on the anonymized medical histories of previous patients. The Cercle™ Biomedical Graph is the best representation of all medical records in RWD and RWE available on the market today. The Cercle™ Biomedical Graph also benefits patients directly by providing personalized insights that they can discuss with their doctors to make more informed health decisions. 

This treasure trove of information is invaluable for individual clinics, hospitals and it’s also crucial to improve the research of new treatments, track secondary effects of new treatments, discover new genomics approaches and help patients navigate the complexity of their health journeys. And the technology has unlimited potential to help clinics provide their patients with truly personalized healthcare that takes their unique medical histories and concerns into account.

The anonymized data in the Cercle™ Biomedical Graph is also incredibly diverse, meaning that it encompasses the medical journeys of millions of people of all ages, genders, medical backgrounds and treatment paths. It is a revolutionary step for healthcare—there is no other such product that can scale like the Cercle™ Biomedical Graph or draw insights from billions of data points as quickly. This technology will support doctors, clinics, biotech and pharmaceutical researchers, and healthcare communities across many healthcare verticals and needs.

If you think of it like drawing a map, we began with the essentials: How do you get from point A to point B? When you want to drive from New York to Boston, the first thing you need to know is that you’re driving north. That’s pretty much the status quo of most medical data today. As Cercle improves and grows, it’s like the equivalent of adding more detail to a map, so you can see your possible routes and decide which one seems right for you.

From day one, we knew that safeguarding privacy was our most important priority. That’s why we anonymize every bit of data before it’s added to the Cercle™ Biomedical Graph. We’re not just HIPAA compliant—the Cercle™ Biomedical Graph is designed to never manage any personal information at all. We consulted with physicians, medical experts, molecular biologists and data scientists to ensure that we’re delivering accurate, and actionable insights.

While we’re excited about the many possible uses of the Cercle™ Biomedical Graph, we decided to start with one of the least researched areas of health: women’s health, and in particular, fertility and reproductive care. 

Across the board, women’s health is chronically under researched and historically underfunded. Even as the use of assisted reproductive technology has doubled in the past decade, there is very little data out there about fertility care. As a result, too many people don’t get the information they want and need at important moments in their lives. 

The fertility journey for those considering egg freezing, in vitro fertilization (IVF) or intrauterine insemination (IUI) can be so much better than it is today—and people trying to conceive deserve better. That’s why we’re excited to launch the Beta version of Luce, a fertility companion for women and doctors that analyzes data from thousands of treatment cycles to help people make more informed decisions for their fertility journeys.

Powered by the Cercle™ Biomedical Graph, Luce is a patient-friendly companion app that connects data from thousands of women, fertility clinics, genetics clinics, mental health providers, and OB-GYNs to identify similar fertility journeys, then deliver personalized insights based on those similarities. Luce is not only a companion to women—it is also a complementary product for doctors to discuss insights and potential paths forward with their patients.

If you’re currently on your fertility journey, I hope you’ll try Luce by signing up for an account today. We truly believe that secure data can help you find clarity on your path forward with the confidence and support you deserve. And if you choose to become a Luce member, thank you. You’re adding knowledge to our community that will help light the ways for others like you.